ARCHIVES

Promising Results For Glivec In CML Continue, FDA Grants Priority Review

This article is from The Cancer Letter archive.

Vol. 24 No. 4 | April 27, 2001

Download PDF Visit The Full Archive

Related Articles

Avastin-Zybrestat Combination Increases Progression-Free Survival in Phase II Trial

March 28, 2014

IOM Selects Advisors To Defense Department

February 5, 1993

New Predictive Score May Help In Planning Adjuvant Therapy

September 26, 2008

ACS Research Grants Hit $78.2 Million

July 18, 1986

NCAB Committee Ok’s Recompetition of OD Support Contract

May 22, 1992

Moertel Criticizes Janssen Over Levamisole Price, Delivers Final Report On Intergroup Adjuvant Trial

June 12, 1992